Proprietary Data, Expert Analysis And Thought-Provoking Insights
Digital technologies are transforming clinical operations at global pharmaceutical companies. These firms have a huge opportunity to boost drug development by responding to participants’ needs and significantly improving internal processes and data management. They must also address the industry’s growing interest in decentralized studies that best meet patient needs. To determine digital excellence maturity at the world’s largest pharma firms, we surveyed senior clinical ops leaders whose remit includes digital transformation and evaluated the responses using our Digital Excellence Maturity Assessment framework, including eleven key digital capabilities for clinical ops. We found that digital maturity, capability prioritization, and best practice adoption varied widely; the best firms excel at study design and the implementation of patient data capture tools.